Suppr超能文献

核因子κB受体激活剂(RANK)/RANK配体相互作用对黏膜树突状细胞功能的调节:对耐受性诱导的影响

Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.

作者信息

Williamson Eilidh, Bilsborough Janine M, Viney Joanne L

机构信息

Department of Inflammation, Immunex Corp., Seattle WA 98101, USA.

出版信息

J Immunol. 2002 Oct 1;169(7):3606-12. doi: 10.4049/jimmunol.169.7.3606.

Abstract

The mucosal immune system is uniquely equipped to discriminate between potentially invasive pathogens and innocuous food proteins. While the mechanisms responsible for induction of mucosal immunity vs tolerance are not yet fully delineated, recent studies have highlighted mucosal dendritic cells (DC) as being important in determining the fate of orally administered Ag. To further investigate the DC:T cell signals involved in regulating the homeostatic balance between mucosal immunity and tolerance, we have examined the expression and function of the TNFR family member receptor activator of NF-kappaB (RANK) and its cognate ligand, RANKL, in vitro and in vivo. Our data show that although DC isolated from mucosal lymphoid tissues expressed similar levels of surface RANK compared with DC isolated from peripheral lymphoid tissues, DC from the distinct anatomical sites displayed differential responsiveness to RANK engagement with soluble RANKL. Whereas splenic DC responded to RANKL stimulation with elevated IL-12 p40 mRNA expression, Peyer's patch DC instead preferentially displayed increased IL-10 mRNA expression. Our data also show that the in vivo functional capacity of mucosal DC can be modulated by RANKL. Treatment with RANKL in vivo at the time of oral administration of soluble OVA enhanced the induction of tolerance in two different mouse models. These studies underscore the functional differences between mucosal and peripheral DC and highlight a novel role for RANK/RANKL interactions during the induction of mucosal immune responses.

摘要

黏膜免疫系统具有独特的能力,能够区分潜在的侵袭性病原体和无害的食物蛋白。虽然负责诱导黏膜免疫与耐受的机制尚未完全阐明,但最近的研究强调黏膜树突状细胞(DC)在决定口服抗原的命运方面起着重要作用。为了进一步研究参与调节黏膜免疫与耐受之间稳态平衡的DC:T细胞信号,我们在体外和体内检测了NF-κB受体激活剂(RANK)这一TNF受体家族成员及其同源配体RANKL的表达和功能。我们的数据表明,尽管从黏膜淋巴组织分离的DC与从外周淋巴组织分离的DC相比,表面RANK表达水平相似,但来自不同解剖部位的DC对可溶性RANKL与RANK结合的反应性存在差异。脾DC对RANKL刺激的反应是IL-12 p40 mRNA表达升高,而派尔集合淋巴结DC则优先表现出IL-10 mRNA表达增加。我们的数据还表明,黏膜DC的体内功能能力可被RANKL调节。在口服可溶性卵清蛋白时体内给予RANKL,可增强两种不同小鼠模型中的耐受诱导。这些研究强调了黏膜DC和外周DC之间的功能差异,并突出了RANK/RANKL相互作用在诱导黏膜免疫反应过程中的新作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验